What is Symbio Research?
Symbio Research operates as a specialized Contract Research Organization (CRO), delivering comprehensive clinical trial solutions. The company focuses on dermatology, aesthetics, gastroenterology, and inflammation, boasting a track record of over 650 trials and 70 FDA approvals. Their service portfolio encompasses clinical trial project management, regulatory affairs, and medical writing, all aimed at accelerating product market entry while upholding clinical excellence. Symbio Research prioritizes building robust relationships with sponsors and investigators through proactive engagement and a steadfast commitment to client success.
How much funding has Symbio Research raised?
Symbio Research has raised a total of $1.4M across 1 funding round:
Debt
$1.4M
Debt (2021): $1.4M with participation from PPP
Key Investors in Symbio Research
PPP
Public-Private Partnership
What's next for Symbio Research?
The recent major strategic investment signals a period of accelerated growth and potential expansion for Symbio Research. This capital infusion is likely to be directed towards enhancing its service offerings, expanding its operational capacity, and potentially exploring new therapeutic areas or geographical markets. The company's focus on specialized fields and its proven success in navigating regulatory pathways position it for continued advancement in the competitive CRO landscape.
See full Symbio Research company page
